Skip to main content
. Author manuscript; available in PMC: 2016 Jun 10.
Published in final edited form as: J Pediatr. 2010 Jan;156(1):155–157. doi: 10.1016/j.jpeds.2009.07.021

Table.

Laboratory and clinical course of 6 patients with acute hemolytic anemia from presumed L. reclusa toxin exposure. All laboratory values are at clinical presentation except for the hemoglobin nadir (Lowest Hb), peak reticulocyte count, and the maximum total bilirubin value (Peak T Bili).

Patient 1
17 y/o AAF
Patient 2
16 y/o AAM
Patient 3
13 y/o AAM
Patient 4
12 y/o AAF
Patient 5
13 y/o AAF
Patient 6
14 y/o AAF
Initial Hb (gm/dL) 4.8 12.9 8.8 6.5 4.9 13.7
Lowest Hb (gm/dL) 4.8 7.1 8.7 5.6 4.5 5.9
Initial Reticulocytes
× 109/L (%)
25 (1.6%) 41 (1.1%) 181 (6.3%) 177 (8.3%) 207 (14.6%) 125 (4.2%)
Peak Reticulocytes
× 109/L (%)
255 (8.3%) 229 (8.8%) 226 (7.4%) 222 (11.7%) 364 (15.1%) 155 (3.8%)
Platelets (× 109/L) 260 182 535 383 344 222
WBC (× 109/L) 37.4 16.6 17.9 18.8 35.5 19
ANC (× 109/L) 34.4 11.0 9.7 11.8 20.6 14.8
Peak T Bili (mg/dL) 13.8 7.2 3.2 3.2 2.7 15.1
LDH (U/L) Not available Not available Not available 4656 483 2611
DAT Positive Positive Positive Positive Positive Positive
 Surface IgG Trace Positive Positive
 Surface C3 3+ Positive 2+ 1+ 3+ Positive
Hospital admission ICU Inpatient Inpatient Inpatient ICU ICU
BP Support IV fluids,
Dopamine
Not required Not required Not required IV fluids,
Dopamine
IV fluids
PRBC Transfusion 4 units 2 units Not required Not required 1 unit 5 units
Surgical wound care I&D Bedside Debride Not required Not required Not required Not required